A 800 MHz nuclear magnetic resonance (NMR) spectrometer at the University of Liverpool is being rebuilt to analyse both liquids and solids, a dual capability that no other UK instrument at this field strength currently offers. NMR spectroscopy reveals molecular structure, dynamics, and interactions. Higher magnetic fields give sharper resolution and greater sensitivity, letting researchers see details that lower-field instruments miss. The upgraded machine will join a UK-wide hub-and-spoke network, with up to 30% of its time reserved for external academic and industrial users across the physical and life sciences. If the upgrade succeeds, UK researchers will gain access to a tool that can determine the 3D structures of biological and chemical molecules, track how linear polypeptides fold into complex shapes—and how that process goes wrong in neurodegenerative diseases and cancer—analyse catalytic processes in complex materials, and monitor metabolism inside living cells. The instrument is intended to support national priority areas including advanced materials, renewable energy, industrial biotechnology, synthetic biology, and core health challenges. It is also designed to attract industrial partnerships and respond flexibly to strategic initiatives such as the Industrial Strategy Challenge Fund.
View original technical description
The objectives of the proposal are to upgrade and reconfigure the existing 800 MHz solution-state NMR spectrometer to a dual solution-solid NMR spectrometer. This dual configuration is similar to other NMR systems successfully used worldwide and is strategically differentiated from any of the existing UK high field provision. The upgraded system will provide opportunities to do new science not previously possible in Liverpool and the UK, in both academia and industry. In addition, the new system will become one component of the UK hub and spoke network of NMR instrumentation, with up to 30% of its time offered to the wider UK research community across the physical and life sciences, and is configured to complement other high field instruments (> 600 MHz), providing the flexibility for NMR infrastructure at the highest available field to respond to changes in research priorities and opportunities. NMR spectroscopy is the most versatile of all the analytical tools; it provides insights into molecular structure, dynamics, and interactions. The higher sensitivity and resolution delivered with very-high field NMR are transformative, providing information not accessible at lower field strength. The new dual solution-solid capabilities will support, extend and enhance research activities where there is excellence in the region and UK-wide (see Academic Beneficiaries) such as advanced chemical- and bio- materials, renewable energy, industrial biotechnology, personalised medicine and human/animal health. They will also strengthen and/or catalyse new academic-industrial collaborations, focusing on and exploiting areas of priority to the region and the UK. Examples include: (1) Structure determination of biological and chemical molecules and supra-molecular aggregates in solution and solid states; (2) Folding of linear polypeptides into complex biologically-active 3D structures, and the ways in which these processes can be altered or subverted in neurodegenerative diseases and cancer; (3) Catalytic processes, and the detailed analysis of the structure and dynamics of complex materials; (4) Metabolism within intact cells and organisms. UK research support targets strengthening the UK's competitive position in key priority areas. By upgrading to state-of-the-art instrumentation, the proposed 800 MHz upgrade will enable UK research communities to continue to make major contributions across the range of research challenges aligned with national agendas and strategic priorities, and to respond rapidly and flexibly to initiatives such as the Industrial Strategy Challenge and the Global Challenges Research Funds. We will deliver on this major investment in NMR by: (1) Progressing a challenging scientific agenda based on national priorities such as advanced materials, renewable energy, industrial biotechnology and synthetic biology, and core health challenges; (2) Ensuring that the UK is at the forefront of NMR technique development in both solution and solid state, by capitalising on our collective knowledge and experience, and providing training to the community through courses and summer schools; (3) Attracting industrial support, partnerships and engagement, founded upon a strong collective track record of using our scientific capabilities and assets to support economic growth; (4) Maximising the effective use of capital assets to ensure efficient provision of NMR access, building on our pioneering experience in equipment sharing of the N8, and operating and managing national facilities, within a long-term sustainability plan; (5) Aligning with the core individual institutional strategy of the University, as demonstrated by substantial institutional contributions towards the costs; (6) Developing annual reporting systems and symposia to disseminate findings and open new research strategies, and monitoring performance using defined Key Performance Indicators.
Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.
Is something wrong? Let us know